DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Alnylam Pharmaceuticals, Inc. (ALNY)
« Back to company indexALNY Chatter Timeline
Stock Ticker for ALNY
Most Active Tweeters for ALNY
| User | Tweets |
|---|---|
| @FlashAlert_me | 7 |
| @Gambiste1 | 5 |
| @RNAiAnalyst | 4 |
| @ConsumerFeed | 2 |
| @WKRBNews | 1 |
Recent Tweets for ALNY
 |
@42Stocks #Alnylam Pharmaceuticals up 1.8% = $138.8 million gain. $ALNY has made notable gains in 5 of the last 14 trading se… https://t.co/iOFrIH8C86 July 15th 2019, 6:07pm |
 |
@RNAiAnalyst $ALNY's competing Lumasiran already head BTD. July 15th 2019, 7:07am |
|
@RNAiAnalyst $ALNY rationalizes that liver enzyme elevations only in patients w/ anti-HCV antibodies. 2 questions: 1) how many… https://t.co/XsRZh8e8Y6 July 15th 2019, 5:07am |
 |
@battagliame30 @RNAiAnalyst You talking older $ALNY RNAi-triggers possibly being more probed to miRNA homology? July 13th 2019, 6:07pm |
 |
@MogulAzam RT @RNAiAnalyst: Fitusiran another one of those RNAi triggers not optimized for targeting specificity. New generation different. $ALNY http… July 13th 2019, 3:07pm |
 |
@CentralChartsEN $ALNY #ALNYLAMPHARMACEUTICALS - Daily: In a bearish trend, the price of ALNYLAM PHARMACEUTICALS INC. tries to infla… https://t.co/2lwXSziz8d July 12th 2019, 8:07am |
 |
@Londinia_IA $ALNY #ALNYLAMPHARMACEUTICALS - Daily: In a bearish trend, the price of ALNYLAM PHARMACEUTICALS INC. tries to infla… https://t.co/OzjrRqtvtQ July 12th 2019, 8:07am |
 |
@CarlyHFierce Alnylam recruits former Shire exec to replace departing CFO Soni: https://t.co/FLnBzeSFEm $ALNY #pharma July 12th 2019, 7:07am |
 |
@marketexclusive $ALNY Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Files An 8-K Departure of Directors or Certain Officers; Electio… https://t.co/UoT8PbPZxN July 11th 2019, 5:07pm |
 |
@fintel_io $ALNY / Alnylam Pharmaceuticals files form 8-K https://t.co/2VCNl4PxYC - Regulation FD Disclosure, Departure of Dir… https://t.co/lluPA6xBcS July 11th 2019, 4:07pm |
 |
@confcalltran Alnylam Pharmaceuticals Announces Transition Of Chief Financial Officer https://t.co/UlPt8aTGLH $ALNY July 11th 2019, 4:07pm |
 |
@filingsdb New Form 8-K filed by ALNYLAM PHARMACEUTICALS, INC. $ALNY - https://t.co/jSljjpKeZO July 11th 2019, 4:07pm |
|
@RNAiAnalyst $ALNY does CFO 'transition' signal cash burn to decrease? https://t.co/kxlXVdXxgf July 11th 2019, 12:07pm |
 |
@robstanislaro RT @JohnCendpts: Alnylam’s Maraganore switches ‘perhaps the best CFO in mid-cap biotech’ with Shire vet Jeff Poulton $ALNY https://t.co/Ud0… July 11th 2019, 11:07am |
 |
@JohnCendpts Alnylam’s Maraganore switches ‘perhaps the best CFO in mid-cap biotech’ with Shire vet Jeff Poulton $ALNY https://t.co/Ud0VURxmgu July 11th 2019, 10:07am |
 |
@AndrewE_Dunn Inbox: $ALNY CFO Manmeet Soni resigning "to pursue other interests." Will continue at Alnylam through Aug. 12, whil… https://t.co/1m0yEc8Jd5 July 11th 2019, 8:07am |
 |
@ProVesting $ALNY: Alnylam Pharmaceuticals Announces Transition of Chief Financial …: https://t.co/SeIgY5PXwA July 11th 2019, 8:07am |
 |
@Gambiste1 RT @trade4me_net: $ALNY Growth Stock, V & W Shape, Breakout Mode, Volume Accumulation, Institutional Buying $ 198.6 M, Institutional Owners… July 11th 2019, 7:07am |
 |
@trade4me_net $ALNY Growth Stock, V & W Shape, Breakout Mode, Volume Accumulation, Institutional Buying $ 198.6 M, Institutional… https://t.co/LRV3uJN1ky July 10th 2019, 11:07pm |
 |
@AmericanBanking Alnylam Pharmaceuticals, Inc. $ALNY Receives Consensus Recommendation of “Buy” from Analysts https://t.co/KT3qlNPpLc #stocks July 9th 2019, 2:07pm |
 |
@WKRBNews Brokerages Expect Alnylam Pharmaceuticals, Inc. $ALNY Will Announce Quarterly Sales of $47.29 Million https://t.co/DzulJa50gu #markets July 8th 2019, 9:07pm |
 |
@ConsumerFeed Brokerages Expect Alnylam Pharmaceuticals, Inc. $ALNY Will Announce Quarterly Sales of $47.29 Million https://t.co/Pt5biwIxgW July 8th 2019, 9:07pm |
|
@Gambiste1 RT @AlecJones10: Definitely not a clean safety profile for fitu $alny https://t.co/ACS2WIsZs6 July 7th 2019, 11:07am |
|
@Gambiste1 RT @MSS1992BIO: $alny this suggests to me that continued dosing of escgalnac is definitely not safe. $mdco will not see these side effects… July 7th 2019, 11:07am |
 |
@MSS1992BIO $alny this suggests to me that continued dosing of escgalnac is definitely not safe. $mdco will not see these side… https://t.co/cGbgIdaboK July 7th 2019, 10:07am |
|
@ConsumerFeed Brokerages Expect Alnylam Pharmaceuticals, Inc. $ALNY to Announce -$1.81 Earnings Per Share https://t.co/Od5qBOomcy July 6th 2019, 10:07pm |
 |
@IRAMarketReport Zacks: Analysts Anticipate Alnylam Pharmaceuticals, Inc. $ALNY Will Post Quarterly Sales of $47.29 Million https://t.co/TW1GZglI4U #markets July 6th 2019, 10:07pm |
 |
@chaffeybreeze Zacks: Analysts Anticipate Alnylam Pharmaceuticals, Inc. $ALNY Will Post Quarterly Sales of $47.29 Million https://t.co/Hjn7WQygAS #stocks July 6th 2019, 10:07pm |
|
@AlecJones10 Definitely not a clean safety profile for fitu $alny https://t.co/ACS2WIsZs6 July 6th 2019, 9:07pm |
 |
@FlashAlert_me $ALNY filed form CT ORDER on July 05, 10:07:37 https://t.co/D3WI1uFL2k July 5th 2019, 10:07am |
 |
@registrarjourn Alnylam Pharmaceuticals, Inc. $ALNY Expected to Announce Earnings of -$1.81 Per Share https://t.co/f3TZzOlCEc July 4th 2019, 2:07pm |
 |
@EnterpriseLeade Alnylam Pharmaceuticals, Inc. $ALNY Expected to Announce Earnings of -$1.81 Per Share https://t.co/0pVL72EeL7 July 4th 2019, 2:07pm |
 |
@dispatchtribune Brokerages Expect Alnylam Pharmaceuticals, Inc. $ALNY to Announce -$1.81 EPS https://t.co/cfBz4AUZj6 July 4th 2019, 2:07pm |
 |
@OlympiaReport Alnylam Pharmaceuticals, Inc. $ALNY Expected to Announce Earnings of -$1.81 Per Share https://t.co/rcZsQ4OjeH July 4th 2019, 2:07pm |
 |
@IonisDisrupts @RNAiAnalyst #Onpattro is so much better that $Alny withheld 2nd year data of ole. $ions didn’t. July 4th 2019, 11:07am |
|
@Gambiste1 RT @SwingTradeIdeas: $ALNY - Alnylam (ALNY) Upgraded to Strong Buy: What Does It Mean for the Stock? https://t.co/Mr1R677rVw July 4th 2019, 10:07am |
 |
@SwingTradeIdeas $ALNY - Alnylam (ALNY) Upgraded to Strong Buy: What Does It Mean for the Stock? https://t.co/Mr1R677rVw July 4th 2019, 10:07am |
 |
@OTSociety Investigational #RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of #Myasthenia Gravis $ALNY… https://t.co/4JrlkLgCtK July 3rd 2019, 11:07am |
|
@Gambiste1 RT @RNAiAnalyst: $abus royalty to $ALNY's Patisiran worth more than I had thought. Sold to a pension plan in Ontario no less! https://t.co… July 3rd 2019, 3:07am |
|
@RNAiAnalyst $abus royalty to $ALNY's Patisiran worth more than I had thought. Sold to a pension plan in Ontario no less! https://t.co/LQSdppa81h July 2nd 2019, 4:07pm |
|
@FlashAlert_me $ALNY filed SEC form 4: Director BONNEY MICHAEL W: https://t.co/Q8CeGCPjdo July 2nd 2019, 4:07pm |
|
@FlashAlert_me $ALNY filed SEC form 4: Director SCHULMAN AMY W: https://t.co/GLyiaNKor2 July 2nd 2019, 4:07pm |
|
@FlashAlert_me $ALNY filed SEC form 4: Director SHARP PHILIP A: https://t.co/aSgbOV3wHw July 2nd 2019, 4:07pm |
|
@FlashAlert_me $ALNY filed SEC form 4: Director SCHIMMEL PAUL: https://t.co/jIySNfqTr3 July 2nd 2019, 4:07pm |
 |
@InsiderAlertsIA $ALNY: New Insider Filing on Director DENNIS A AUSIELLO: https://t.co/gPBROHB3FP July 2nd 2019, 4:07pm |
|
@FlashAlert_me $ALNY filed SEC form 4: Director Reitan Colleen F: https://t.co/4uaA9tMNBg July 2nd 2019, 4:07pm |
|
@FlashAlert_me $ALNY filed SEC form 4: Director PAUL STEVEN M: https://t.co/dcdpgkC60r July 2nd 2019, 4:07pm |
 |
@bthefirsttoknow $ABUS $ALNY Arbutus Sells Part of its ONPATTRO™ (patisiran) Royalty Interest to OMERS https://t.co/9HXENLtzTY July 2nd 2019, 4:07pm |
 |
@SwingTradeBot 50 DMA Resistance today: $CONE $ALNY ... https://t.co/mnYaiRq1wk July 2nd 2019, 3:07pm |
 |
@portefeuillefun Sold 200 $ALNY at $73.36, now 300 #vssporte shares. July 2nd 2019, 12:07pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.